Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-17

Clinical Trial Update: Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™

View source ↗

Summary

An observational study of Norditropin NordiFlex with the NordiFlex PenMate for growth hormone deficiency in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norditropin NordiFlex (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children | Status: COMPLETED